Cover Image

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated radiation therapy (IMRT) in a concomitant boost concept.

Saved in:
Bibliographic Details
Main Authors: Jensen, Alexandra (Author) , Krauß, Jürgen (Author) , Potthoff, Karin (Author) , Simon, Christian (Author) , Nikoghosyan, Anna (Author) , Lossner, Karen (Author) , Debus, Jürgen (Author) , Münter, Marc (Author)
Format: Article (Journal)
Language:English
Published: 2 April 2012
In: Radiation oncology
Year: 2012, Volume: 7
ISSN:1748-717X
DOI:10.1186/1748-717X-7-57
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1748-717X-7-57
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1748-717X-7-57
Get full text
Author Notes:Alexandra D. Jensen, Jürgen Krauss, Karin Potthoff, Christian Simon, Anna V. Nikoghosyan, Karen Lossner, Jürgen Debus, Marc W. Münter
Description
Summary:To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated radiation therapy (IMRT) in a concomitant boost concept.
Item Description:Published 2 April 2012
Gesehen am 22.08.2018
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/1748-717X-7-57

Similar Items